ArticlePDF Available

Abstract and Figures

Ginkgo biloba is known as ‘living fossils’ as it is the only surviving member of ancient trees. Ginkgo fossils are being known from rocks as old as two hundred million years. This plant is native to China and scattered in broad leaved mixed-mesophytic forest up to 1,100 m and it is located on the border of the Yangtze River valley and on the hill country. The wild population is confined to the Zhejiang province, China. Some other parts also have wild population but those are not up to sufficient numbers. Flavonoids and terpenoids-lactones such as Ginkgolides and bilobalide are the active components and these are unique to the Ginkgo. Plants are used for bladder inflammation and pulmonary disorders, heart abnormalities, skin infections and neurodegenerative disorders. A Ginkgo product by the name of Tebonin is a leading herbal medicine in market. So the consumption of this plant worldwide is very high due to which plant is facing great threats towards its extinction. Ginkgo biloba is listed as endangered plant in the IUCN red list of threatened species. There is hardly any wild population of Ginkgo exists, majority of the trees are existing in the cultivated form and million of the dollar industry has cashed in based on the medicinal properties of the leaves. Resultantly it is possible that this living fossil will survive the short of time. A recommendation for its preservation is that there should be some steps to increase the size of wild populations.
No caption available
… 
Content may be subject to copyright.
Nova Journal of Medical and Biological Sciences Page: 1
Nova Explore Publications
Nova Journal of Medical and Biological Sciences
Vol. 3(4), 2014:1-3
PII: S2292793X1400021-3
www.novaexplore.com
Review Article
Status of Maiden Hair Tree-Ginkgo biloba; Living Fossils Becoming
Endangered
Humma Mehreen Sadaf 1, Yamin Bibi1, Muhammad Arshad1, Muhammad Shoaib Amjad1
1Department of Botany, PMAS, University of Arid Agriculture Rawalpindi, Pakistan
Corresponding Author: Muhammad Shoaib Amjad, Department of Botany, PMAS, University of Arid Agriculture Rawalpindi,
Pakistan, E-mail: malikshoaib1165@yahoo.com
Abstract
Ginkgo biloba is known as ‘living fossils’ as it is the only surviving member of ancient trees. Ginkgo fossils are being known from
rocks as old as two hundred million years. This plant is native to China and scattered in broad leaved mixed-mesophytic forest up to
1,100 m and it is located on the border of the Yangtze River valley and on the hill country. The wild population is confined to t he
Zhejiang province, China. Some other parts also have wild population but those are not up to sufficient numbers. Flavonoids a nd
terpenoids-lactones such as Ginkgolides and bilobalide are the active components and these are unique to the Ginkgo. Plants are used
for bladder inflammation and pulmonary disorders, heart abnormalities, skin infections and neurodegenerative disorders. A Ginkgo
product by the name of Tebonin is a leading herbal medicine in market. So the consumption of this plant worldwide is very high due
to which plant is facing great threats towards its extinction. Ginkgo biloba is listed as endangered plant in the IUCN red list of
threatened species. There is hardly any wild population of Ginkgo exists, majority of the trees are existing in the cultivated form and
million of the dollar industry has cashed in based on the medicinal properties of the leaves. Resultantly it is possible that this living
fossil will survive the short of time. A recommendation for its preservation is that there should be some steps to increase t he size of
wild populations.
Keywords: Ginkgo biloba, conservation, endangered, threats, uses.
Introduction
Ginkgo biloba is known as ‘living fossils’ as it is the only surviving member of ancient trees. A German surgeon, Englbert Kaempfer,
first time used the term “Ginkgo” in 1712 and Linnaeus termed it Ginkgo biloba in 1771 (Gertz and Kiefer 2004).
It is the only member in its family, order and class. No other living individual has such distinction. Ginkgo fossils are being known
from rocks as old as two hundred million years. This plant was planted in temple grounds in China and later on it spread to J apan.
Single tree may live as long as thousands of the years (Bown, 2001).
Kingdom
Phylum
Class
Order
Family
Genus
Species
Plantae
Tracheophyta
Ginkgoopsida
Ginkgoales
Ginkgoaceae
Ginkgo
Biloba
Table 1.Taxonomic and Morphological Description
Maiden hair tree is a dioecious plant having almost 7 m broad trunk and 30 m tall while some individuals in China reach up to 50 m in
height. Young trees are slender and sparsely branched. The crown becomes broader with the age of the tree. The tree is deep rooted
which make it resistant to the wind. Ginkgo grows in the well-drained environment. The leaves are very distinctly fan out into two
lobes hence the name is given biloba (two lobes). Leaves resembles to maiden hair fern due to which it is called as maiden hair tree.
(Mckenna et al., 2001).
Male plants contain the microspore in the microsporangiophore which is loosely arranged in microstobilli. Female plants do not
produce cones. Two pendulous ovules borne on the shoots and after pollination, one or both of them develops into the seeds. The seed
is approximately 1.52.0 cm long. The outer layer of seeds is light yellow-brown. Fruit is soft and rich in butyric acid and it produce
smell like rancid butter when fallen (Raven et al., 2005; Plotnik, 2000).
The fertilization of seeds takes place via motile sperm, just like cycads. Sperm of the Ginkgo were first time discovered in 1896 by the
Japanese scientist Sakugoro Hirase. The sperm have multi-layered structure and several thousand flagella form at the base. These
flagella make the sperm motile which help in fertilization (Vanbeek, 2000; Hirase, 1896; Dallimore, 1967).
Distribution
This plant is native to China and scattered in broad leaved mixed-mesophytic forest up to 1,100 m and it is located on the border of the
Yangtze River valley and on the hill country (Wang, 1961; Zheng, 1992).
The attractive maidenhair tree has been widely planted as an ornamental, and cultivated individuals exist around the world. Trees were
traditionally planted in temple gardens in Japan and China. Fossils records show that there were at least 16 genera of the family
Nova Journal of Medical and Biological Sciences Page: 2
ginkgoaceae contributing a significant part of the vegetation of the world. Now it is represented by a single species Ginkgo biloba
(Willis and McElwain, 2002).
The wild population is confined to the Zhejiang province, China. Some other parts also have wild population such as Guizhou,
Sichuan and Guangxi Provinces but these populations are not up to sufficient numbers (Liang, 1993).
Figure 1: Distribution of Ginkgo
Active Components
The therapeutic benefit of the plant is mainly because of two active group of constituents flavonoids and terpenoids-lactones such as
Ginkgolides and bilobalide which are unique to the Ginkgo (Smith and Luo, 2004). Ginkgolides are diterpenes with 5 types A, B, C, J,
and M while Bilobalides are sesquiterpene trilactone. Other minor active constituents include proanthocyanidins, various orga nic acids
and sugars. (DeFeudis and Drieu, 2000).
Traditional Uses
Nuts of the Ginkgo in roasted form are served in Japanese bars as frills to drinks. Fresh or pre-soaked dried nuts are used in soups. The
nuts yield edible oil Fruit of the tree prepared by cooking and fermentation and used as delicacy in weddings. The tree because of its
ornamental value is also grown in the many part of the Europe. The plant is surprisingly resistant to the pollution and insect diseases
due to which it is preferably grown in the urban areas. This plant also has fire resistance properties (Mabberley, 1998; Bilia, 2002).
Medicinal Uses
Nuts used for the treatment of bladder inflammation and pulmonary disorders such as cough and asthama. Leaves are used to tre at
lungs and heart abnormalities and for the treatment of skin infections also (Mahady, 2002). Leaf extract have the potential to treat
neurodegenerative disorders including cardiovascular diseases Alzheimer’s, age -related macular degeneration, stress, cancer, ,
memory loss and psychiatric disorders (Ramassamy et al., 2007). Ginkgo leaf extract also have antidepressant activity (DeFeudis and
Drieu, 2004). Extract of the Ginkgo leaves reduces ROS accumulation and the neuron apoptosis which is consider as the main source
of the neurodegenerative disorders (Ergun et al., 2005; Ahlemeyer and Krieglstein 2003; Bastianettoet al., 2000).
Ginkgo supplements are usually taken in the range of 40200 mg per day. In 2010, a meta-analysis of clinical trials has shown Ginkgo
to be moderately effective in improving cognition in dementia patients[39] 40][41]
Side Effects
Some adverse effects of the Ginkgo extract have been reported which is mainly due to the over consumption. These includes
dizziness, allergic skin reactions, gastrointestinal disturbances, excessive bleeding, headaches (De Smet, 2002; Benjamin et al., 2001;
Vale, 1998; Kleijnen and Knipschild, 1992; Skogh 1998).
Conservation Status
This is the only species in the genus. It is long-living and has an ancient geological record, appearing in the Jurassic. Ginkgo was
believed to existing only in cultivated form until wild populations were discovered late in the 20th century. According to IUCN
criteria, Ginkgo biloba is listed as endangered plant in the IUCN red list of threatened species (Endangered B1+2c ver 2.3) that’s why
this plant must receive the conservation measures (Fu and Jin, 1992).
Threats of its Extinction
There is hardly any wild population of Ginkgo exists and majority of the trees are existing in the cultivated form. This is mainly
cultivated in the Japan, China, South Korea and North Korea. The consumption of this plant worldwide is very high. 1.5-2.0 million
kg of the Ginkgo Leaves are harvested per year for the medicinal purpose. A third part of which is consume by Germany (WWF
Journal, 2000).
Nova Journal of Medical and Biological Sciences Page: 3
A Ginkgo product by the name of Tebonin is a leading herbal medicine in market. This is a famous herbal medicine product in
Europe. It is one of the top ten best selling herbs in the United Kingdom. It is also utilized for timber in China which is a serious
threat. Female trees are not preferred for its cultivation because of its foul smell produced by seeds (Behrens, in prep).
There was only a single wild population of Ginkgo located in Tianmushan (Zhejiang Province). In 1984, 244 individuals of Gink go
population were reported in the Tianmu. Seedlings of Ginkgo were quite rare. Ginkgo is thought to be "pioneer" species in its local
environment (Del Tredici et al., 1992). According to a survey conducted in 1989 it contained only one hundred sixty seven (167)
individuals (Del Tredici et al., 2002). So there was a great decline in the population. Nevertheless, three additional wild populations
have been reported: Longchou (Guangxi Province), Wuchuanshan (Guizhou Province) and Dahong (Hubei Province) (Zheng et al.,
2004).
Conservation Measures
The Ginkgo biloba has been extensively growing in cultivation form for several centuries. In Pakistan, NARC has set up an herbal
garden in which Ginkgo biloba is growing in cultivated form (Marwat and Shinwari, 1996). It is doubtful whether the species still
present in the wild or not. Currently there are no projects for conservation in place. Although cultivated trees are present all over the
world but million of the dollar industry has cashed in based on the medicinal properties of the plant. Resultantly it is poss ible that this
living fossil will survive the short of time. A recommendation for its preservation is that there should be some steps to increase the
size of wild populations.
References
1. Ahlemeyer, B., Krieglstein J. 2003. Neuroprotective effects of Ginkgo biloba extract. Cell. Mol. Life. Sci., 60:177992.
2. Bastianetto, S., Ramassamy C., Dore S., Christen Y., Poirier J., Quirion R. 2000. The Ginkgo biloba extract (EGb 761) protects
hippocampal neurons against cell death induced by beta-amyloid. Eur. J. Neurosci., 12:188290.
3. Behrens, J. (in prep.) Towards Sustainable Sourcing Of Medicinal Plants by the UK Herbal Medicine Industry.Report for Plant life UK,
London.
4. Benjamin, J., Muir T., Briggs K., Pentland B. 2001. A case of cerebral haemorrhagecan Ginkgo biloba be implicated? Postgrad. Med. J.,
77:1123.
5. Bilia, A. R. 2002. Ginkgo biloba L. Fitoterapia, 73:2769.
6. Bown, D. 2001. The herbal: the essential guide to herbs for living.Pavilion, London.
7. Dallimore, W. 1967. A handbook of Coniferae and Ginkgoaceae, St. Martin's Press, New York, p. 229-233.
8. DeFeudis F. V., Drieu K. 2000. Ginkgo biloba extract (EGb 761) and CNS functions: basic studies and clinical applications. Curr. Drug.
Targets., 1:2558.
9. DeFeudis F. V., Drieu K. 2004. “Stress-alleviating” and “vigilance-enhancing” actions of Ginkgo biloba extract (EGb 761). Drug. Dev.
Res., 62:125.
10. Deltredici, P. 1992. Natural regeneration of Ginkgo biloba from downward growing cotyledonary buds (basal chichi). Am. J. Bot., 79, 522 -
530.
11. DeSmet, P. A. 2002. Herbal remedies. N. Engl. J. Med., 347:204656.
12. Ergun, U., Yurtcu E., Ergun M. A. 2005. Protective effect of Ginkgo biloba against gossypol-induced apoptosis in human lymphocytes.
Cell. Biol. Int., 29:71720.
13. Fu L. G., Jin J. M. 1992. Red Science Press: Beijing.
14. Gertz, H. J., Kiefer M. 2004. Review about Ginkgo biloba special extract EGb 761 (Ginkgo). Curr. Pharm.Des., 10:2614.
15. hirase, S. 1896. Spermatozoid of Ginkgo biloba. (In Japanese) Tokyo Bot. Mag., 10:171.
16. Kleijnen, J., Knipschild, P. 1992. Ginkgo biloba. Lancet, 340:11369.
17. Liang, L. 1993. The Contemporary Ginkgo Encyclopedia of China, Beijing Agric. Univ. Press (in Chinese).
18. Mabberley, D. J. 1998. Paradisus: Hawaiian plant watercolors by Geraldine King Tam. Honolulu Academy of Arts.
19. Mahady G. B. 2002. Ginkgo biloba for the prevention and treatment of cardiovascular disease: a review of the literature. J. Cardiovasc.
Nurs., 16:2132.
20. Marwat Q. and Z. K. Shinwari. 1996. Ethno botanical studies in upper Siran Mansehra, Pakistan, Proc. First, train, Workshop Ethnob.
Appl. Conserv. National Herbarium, PASA (NARC), Islamabad, Pakistan. 73-82.
21. McKenna, D. J., Jones K., Hughes K. 2001. Efficacy, safety, and use of Ginkgo biloba in clinical and preclinical applications. Altern. Ther.
HealthMed., 7:70-90.
22. Plotnik, A. 2000. The Urban Tree Book: An Uncommon Field Guide for City and Town (1st ed.). New York: Three Rivers Press. p. 202
23. Ramassamy, C., Longpre F., Christen Y. 2007. Ginkgo biloba extract (EGb 761) in Alzheimer’s disease: is there any evidence? Curr.
Alzheimer. Res., 4:25362.
24. Raven, P. H., R. F. Evert, S. E. Eichhorn. 2005. Biology of Plants (7th ed.). New York: W. H. Freeman and Company. p. 429 430.
25. Skogh, M. 1998. Extracts of Ginkgo biloba and bleeding or haemorrhage. Lancet, 352:11456.
26. Smith, J. V., Luo Y. 2004. Studies on molecular mechanisms of Ginkgo biloba extract. Appl. Microbiol. Biotechnol., 64:46572.
27. Sun, W. 1998. Ginkgo biloba. In: IUCN 2012. IUCN Red List of Threatened Species. Version 2012.2
28. Tredici, P., Ling H., Yang G. 1992. The Ginkgos of Tian Mu Shan. Conserv. Biol., 2: 202-209.
29. Vale, S. 1998. Subarachnoid haemorrhage associated with Ginkgo biloba. Lancet, 352:36.
30. Vanbeek A. V. 2000. Ginkgo biloba (Medicinal and Aromatic Plants: Industrial Profiles). CRC Press. p. 37.
31. Wang, C. W. 1961. The Forests of China, Maria Moors Cabot Found., publ. 5. Harvard Univ., Cambridge, Mass.
32. Willis, K. J., McElwain J. C. 2002. The Evolution of Plants. Oxford University Press: New York.
33. WWF Journal. 2000. Apotheke Wildnis: Naturmedizin boomt auf. Kosten. Der. Natur. p. 25.
34. Zheng, C. Z. 1992. A preliminary analysis of flora in Tianmu Mountain Reserve. In F. Yang (ed.) Comprehensive investigation R eport on
Natural Resource of Tianmu Mountain Nature Reserve, Science and Technology Press, Hangzhou, (in Chinese), 89-93.
Article
Full-text available
Ginkgo biloba is worldwide an economically valuable tree. The species has nearly got extinct during the Quaternary which likely result in reduction of its genetic variability. This is now conserved in few natural populations in China and number of cultivars which are, however, derived from a few ancient trees, helping the species survival in China through medieval times. Despite the recent interest on ginkgo, however, the detail knowledge of its genetic diversity, conserved in cultivated trees and cultivars remained poor. This limit efficient conservation of its diversity as well as efficient use of the existing germplasm resources. Here we performed genotyping-by-sequencing (GBS) sequencing on 102 ginkgo cultivated germplasm collected to explore their genetic structure, kinship and inbreeding prediction. And for the first time in ginkgo, genome-wide association analysis study (GWAS) was used to try gene mapping of seed traits. The results showed that the most of the germplasm did not show obvious genetic relationship. The size of ginkgo germplasm population expanded significantly around 1500 years ago during the Sui and Tang dynasties. Classification of seed cultivars based on phylogenetic perspective does not support the current classification criteria based on phenotype. Twenty-four candidate genes were localized after performing GWAS on the seed traits. Overall, this study reveal the genetic basis of ginkgo seed traits and shed insights into its cultivation history, these findings will facilitate the conservation and utilization of the domesticated germplasms of this living fossil plants.
Article
Full-text available
Aim: The study was conducted to evaluate the effect of Ginkgo biloba on serum uric acid level when used as add-on therapy to valsartan in hypertensive patients. Patients and Methods: The study was conducted in Private Clinics in Mosul City-Iraq, during a period of sixth months from 15 October 2017 to15 April 2018. The total number of patients enrolled in the study was 50 hypertensive patients using Valsartan mono-therapy of both sexes. The patients were administered Ginkgo biloba 80 mg twice daily and followed for 2 months duration. Their serum uric acid level was determined at baseline level and after 2 months from administration of Ginkgo biloba. Results: There was a significant reduction on serum uric acid level after two months from addition of Ginkgo biloba. Conclusions: This study revealed that Ginkgo biloba could be regarded as natural and relatively safe drug in reducing serum uric acid level.
Article
Full-text available
Discusses the regulation, quality, safety, and efficacy of herbal medical remedies. This paper also highlights individual herbs, such as ginkgo, hawthorn, saw palmetto, and St. John's wort. In conclusion, recommendations for clinicians are given regarding herbal remedies. (PsycINFO Database Record (c) 2012 APA, all rights reserved)
Article
Full-text available
This study describes the origin and early development of a distinct organ of clonal regeneration in Ginkgo biloba, the basal chichi. These aggregates of suppressed shoot buds originate from superficial meristems located in the cotyledonary axils of all Ginkgo seedlings as part of their normal ontogeny. Within 6 wk of germination these buds become embedded in the cortex of the stem, and their subsequent growth and development occurs below the surface of the bark. When stimulated by some traumatic event that damages the seedling axis, one of these embedded cotyledonary buds usually grows down from the trunk to form a woody, rhizomelike basal chichi which, under appropriate conditions, is capable of generating both aerial shoots and adventitious roots. Vegetative regeneration by means of basal chichi has not only contributed to the long-term persistence of G. biloba in the forests of China, but may also have played a role in the remarkable survival of the genus since the Cretaceous. The genus Ginkgo, represented today by the widely cultivated Chinese species G. biloba L., has an evolutionary lineage that dates back to the lower Jurassic, about 190 million years ago. Over this length of time, the genus has undergone much change; yet fossil leaf and wood material from the Cretaceous species G. adiantoides is considered indistinguishable from that of G. biloba, leading many authors to refer to the Ginkgo as a "living fossil"
Article
Full-text available
The question of whether or not Ginkgo biloba still exists in the wild has been debated by botanists, without resolution, for almost a hundred years. Most of the controversy has focused on a single population of trees located on Tian Mu Shan (Tian Mu Mountain) in Zhejiang Province, China, a site of human activities for approximately 1500 years. Regardless of its origin, the Tian Mu Shan Ginkgo population is biologically significant by virtue of its long survival in a semi-natural state under conditions of intense interspecific competition. A total of 167 Ginkgos were counted and measured in the 1018 ha Tian Mu Shan Reserve. Many of the trees were growing on disturbance-generated microsites, such as stream banks, steep rocky slopes, and the edges of exposed cliffs. Forty percent of the censused individuals were multitrunked, consisting of at least two trunks greater than 10 cm in diameter at breast height. Most of these secondary trunks originated from root-like “basal chichi,” that are produced at the base of trees that have experienced damage from soil erosion or other factors. No Ginkgos less than 5 cm in basal diameter were found in the mature forests of Tian Mu Shan. This lack of seedling reproduction is caused by several factors: (1) the lack of sunny microsites suitable for seedling growth, (2) seed collection by people, and (3) seed predation by animals. In the absence of successful seedling establishment, secondary trunk formation from basal chichi is the single most important factor in explaining the long term persistence of Ginkgo on Tian Mu Shan.
Article
This study describes the origin and early development of a distinct organ of clonal regeneration in Ginkgo biloba, the basal chichi. These aggregates of suppressed shoot buds originate from superficial meristems located in the cotyledonary axils of all Ginkgo seedlings as part of their normal ontogeny. Within 6 wk of germination these buds become embedded in the cortex of the stem, and their subsequent growth and development occurs below the surface of the bark. When stimulated by some traumatic event that damages the seedling axis, one of these embedded cotyledonary buds usually grows down from the trunk to form a woody, rhizomelike basal chichi which, under appropriate conditions, is capable of generating both aerial shoots and adventitious roots. Vegetative regeneration by means of basal chichi has not only contributed to the long-term persistence of G. biloba in the forests of China, but may also have played a role in the remarkable survival of the genus since the Cretaceous.
Article
The case of a 56 year old man who suffered a spontaneous intracerebral haemorrhage after regular self medication with the herbal preparation, Ginkgo biloba leaf extract is described, and the possible association is discussed. • The herbal preparation Ginkgo biloba leaf extract is promoted as a remedy for a wide range of conditions (for example, dementia, erectile dysfunction, tinnitus) • There are grounds to suspect an association with intracranial haemorrhage as described in this case • Awareness of these suspicions should encourage proper documentation of all herbal remedies used when patients present to medical staff
Article
This overview is focused on the stress-alleviating and vigilance-enhancing properties of Ginkgo biloba extract (EGb 761) that have been observed in animal models and in humans and that appear useful in explaining the therapeutic effects of the extract on non-cognitive brain functions that may be reflective of mood changes. With regard to its stress-alleviating activity, in rodents EGb 761 facilitates behavioral adaptation, decreases circulating levels of corticosterone, catecholamines, ACTH, and CRH, suppresses the expression of the mitochondrial peripheral benzodiazepine receptor of the adrenal cortex, increases the anxiolytic activity of diazepam, increases arousal by an action that may involve GABAA receptor antagonism, induces anxiolytic-like activity, prevents stress-induced desensitization of hippocampal 5-HT1A receptors, suppresses the down-regulation of hippocampal glucocorticoid receptors, and facilitates decision-making. In humans, EGb 761 has vigilance-enhancing effects that support its clinical use in treating disorders involving stress-induced brain dysfunction and those non-cognitive symptoms of dementia currently classified as “behavioral and psychological symptoms of dementia” (BPSD). Collectively, these findings indicate that EGb 761 is useful for treating symptoms that are now classified as components of BPSD. As drug combinations consisting of EGb 761 and a non-selective cholinesterase inhibitor, an antidepressant drug, or a neuroleptic could possibly be even more useful in treating BPSD, evaluation of such therapy is recommended. Drug Dev. Res. 62:1–25, 2004. © 2004 Wiley-Liss, Inc.